证券记录 · 已归档季度
GOSS
Gossamer Bio, Inc. · Healthcare · Biotechnology
18被追踪持有人
+3Δ持有人
53.94M持有股份
$141.87M报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +20.0% ·
股份流向 +16.8% ·
净新建仓位 +16.7%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | -10 | 149.84M | $24.67M | +3 | −14 |
| Q1 2026 | 73 | -3 | 96.26M | $32.15M | +6 | −9 |
| Q4 2025 | 76 | -1 | 88.23M | $273.50M | n/a | −1 |
| Q3 2025 | 18 | +3 | 53.94M | $141.87M | +3 | n/a |
| Q2 2025 | 12 | 0 | 44.92M | $55.25M | +1 | −1 |
| Q1 2025 | 9 | +1 | 11.42M | $12.56M | +1 | n/a |
| Q4 2024 | 8 | 0 | 11.95M | $10.80M | n/a | n/a |
| Q3 2024 | 7 | 0 | 18.68M | $18.44M | n/a | n/a |
| Q2 2024 | 7 | n/a | 23.16M | $20.86M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 13.85M | +14.0% | $36.42M | 0.0% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | The Vanguard Group ✦ (被动) | 12.01M | +5.2% | $31.59M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 3 | Geode Capital Management ✦ (被动) | 4.69M | +3.0% | $12.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | Fidelity (FMR) ✦ | 4.09M | -44.1% | $10.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (被动) | 3.88M | +56.5% | $10.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Millennium Management ✦ | 3.62M | +629.3% | $9.52M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 2.98M | +9.1% | $7.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 2.29M | +31.1% | $6.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 2.28M | +197.6% | $6.01M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Adage Capital Partners ✦ | 726.80K | 新增 | $1.91M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 646.62K | 新增 | $1.70M | 0.0% | New | 1 | SEC ↗ ×5 |
| 12 | Wellington Management ✦ | 641.72K | 新增 | $1.69M | 0.0% | New | 1 | SEC ↗ ×3 |
| 13 | Arrowstreet Capital ✦ | 635.40K | -43.2% | $1.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 566.42K | n/a | $1.49M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 15 | JPMorgan Chase ✦ | 388.74K | n/a | $1.02M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 16 | Goldman Sachs Group ✦ | 299.58K | n/a | $787,900 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | D. E. Shaw & Co. ✦ | 248.82K | +338.0% | $654,391 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 18 | T. Rowe Price ✦ | 100.66K | +5.6% | $265,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $1.91M | 0.0% |
| AQR Capital Management | $1.70M | 0.0% |
| Wellington Management | $1.69M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 2.17M 股份, $845,282 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据